<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antithrombin III activity was estimated using a chromogenic substrate perioperatively in the plasma of 200 patients undergoing major elective abdominal surgery during low-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> prophylaxis </plain></SENT>
<SENT sid="1" pm="."><plain>With an initial value of 10.9 +/- 2 IU/ml there was a mean postoperative lowering of plasma antithrombin activity in <z:hpo ids='HP_0000001'>all</z:hpo> patients with a minimum on the second postoperative day </plain></SENT>
<SENT sid="2" pm="."><plain>In patients with empirically established increased risk of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> the postoperative <z:hpo ids='HP_0000716'>depression</z:hpo> of antithrombin was significantly more pronounced (P less than 0.01) than in the control groups </plain></SENT>
<SENT sid="3" pm="."><plain>An increased risk prevailed particularly in patients with malignant diseases and in major surgery, i.e. of prolonged duration </plain></SENT>
<SENT sid="4" pm="."><plain>In such cases with increased risk of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> routine assessment of antithrombin III is recommended </plain></SENT>
</text></document>